The adult bovine serum market is anticipated to expand due to rising demand for biopharmaceuticals and vaccines. Biotechnology is used to create biopharmaceuticals, which are pharmaceuticals that come from biological sources like humans, animals, and microorganisms. They are created utilising tissue culture techniques, stem cells, mammalian cells, etc. The production of therapeutic recombinant molecules or biopharmaceuticals requires the employment of cell culture technologies, which have a variety of vital components that preserve the integrity of the cell culture and supply nutrients and signals. Adult bovine serum (ABS) is one of these cell culture components. To promote the development and proliferation of several cell types, ABS is frequently added to basal cell culture media. A rise in demand for adult bovine serum in culture medium has been attributed to rising demand for biopharmaceuticals and vaccinations throughout time. The global adult bovine serum market is anticipated to increase as a result of the growing availability of adult bovine serum from various sources. Key market participants' increased sourcing of adult bovine serum from New Zealand is anticipated to support market expansion over the forecast period.
Coherent Market Insights projects that the market for Adult Bovine Serum is anticipated to be worth US$ 119.3 million in 2022 and US$ 185.1 million by 2030, growing at a 5.6% CAGR during the forecast period (2022-2030).
Top Companies in the Adult Bovine Serum Industry:
1. Sartorius AG
The firm was established in 1870 and has its headquarters in Göttingen, Germany. Sartorius AG produces and sells components and machinery for precise electronic systems. The business manufactures precision scales for electrochemistry, industrial, and laboratory applications. Sartorius produces machinery for cell culture, concentration, fermentation, and purification as well as biomolecular and microbial separations. In 2020, the business purchased a number of Danaher Corporation's assets, including items for the study and creation of cell treatments.
2. Thermo Fisher Scientific
The company was started in 1956 and is located in Waltham, Massachusetts, U.S. The business offers applications, reagents and consumables, and scientific apparatus. Thermo Fisher Scientific stated in January 2021 that it had purchased Groupe Novasep SAS's viral vector maker, Henogen SA, in Belgium. In an all-cash agreement worth US$2.6 billion, the business agreed to acquire Nordic Capital's British diagnostics company, The Binding Site Group, in October 2022.
3. Auckland BioSciences Ltd.
The business was started in 2014 and has its main office in Auckland, Auckland, New Zealand. Auckland BioSciences manufactures and exports high-quality animal-derived serum, plasma, and other products to the international life sciences sector. The target market is specifically veterinary vaccine producers and academic research facilities.
4. Moregate Biotech
The company was founded in 1975 and is located in Bulimba, Queensland, Australia. Leading businesses receive animal sera, protein, plasma, and other by-products from Moregate Biotech that are of the highest quality from Australia and New Zealand. The acquisition of Moregate Biotech, a well-known biotechnology company with a global presence, by ANZCO Foods in April 2022 will increase the company's capability in the healthcare sector.
5. Merck KGaA
The business was founded in 1668 and is headquartered in Darmstadt, Germany. The company is divided into three divisions: healthcare, electronics, and life sciences. In February 2020, it was revealed that Merck's Allergopharma business was being sold to Dermapharm for an undisclosed fee. EMD Serono, the US and Canadian division of the Merck Group, announced in December 2021 that it would buy Chord Therapeutics, a Swiss startup, along with its lead medication, cladribine.
6. Gemini Bio
The business was established in 1985 and is based in California, United States. The company sells foetal bovine, specialised foetal bovine, non-fetal, other human, and animal sera for cell culture, as well as amino acids, antibiotics, antimycotics, culture supplements, albumins, and recombinant proteins as supplements and reagents. In order to further service the biotechnology and cell therapy industries, GeminiBio constructed a new cGMP bioprocess liquid production plant in March 2023.
7. Serana Europe GmbH
The firm was started in 2007 and has its headquarters in Europe. Leading producer and provider of products for cell culture is Serana Europe GmbH. The product line comprises reagents, supplements, buffer solutions, liquid and powdered sterile classical media, animal and human sera, and reagents for cell culture applications.
Definition: Adult Bovine Serum (ABS) is the liquid portion of clotted blood taken from healthy, killed cattle that are at least 12 months old and determined to be suitable for human consumption by ante- and/or post-mortem examination.
